BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 10891379)

  • 1. Human leukemic (HMC-1) mast cells are responsive to 1alpha, 25-dihydroxyvitamin D(3): selective promotion of ICAM-3 expression and constitutive presence of vitamin D(3) receptor.
    Babina M; Krautheim M; Grützkau A; Henz BM
    Biochem Biophys Res Commun; 2000 Jul; 273(3):1104-10. PubMed ID: 10891379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of VDR-responsive gene signatures in breast cancer cells.
    Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ
    Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3.
    Baroni E; Biffi M; Benigni F; Monno A; Carlucci D; Carmeliet G; Bouillon R; D'Ambrosio D
    J Leukoc Biol; 2007 Jan; 81(1):250-62. PubMed ID: 17035339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.
    Healy KD; Frahm MA; DeLuca HF
    Arch Biochem Biophys; 2005 Jan; 433(2):466-73. PubMed ID: 15581603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.
    Ishizuka S; Kurihara N; Miura D; Takenouchi K; Cornish J; Cundy T; Reddy SV; Roodman GD
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):331-4. PubMed ID: 15225795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
    Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
    Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25-Dihydroxyvitamin D3 inhibits tumor necrosis factor-alpha-induced adhesion molecule expression in endothelial cells.
    Martinesi M; Bruni S; Stio M; Treves C
    Cell Biol Int; 2006 Apr; 30(4):365-75. PubMed ID: 16549374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of SCF and TNF-alpha on the up-regulation of cell-surface expression of ICAM-1 on human leukemic mast cell line (HMC)-1 cells.
    Tsang CM; Wong CK; Ip WK; Lam CW
    J Leukoc Biol; 2005 Jul; 78(1):239-47. PubMed ID: 15800027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
    Khanim FL; Gommersall LM; Wood VH; Smith KL; Montalvo L; O'Neill LP; Xu Y; Peehl DM; Stewart PM; Turner BM; Campbell MJ
    Oncogene; 2004 Sep; 23(40):6712-25. PubMed ID: 15300237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
    Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
    Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
    Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells.
    Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
    J Cell Biochem; 2007 Apr; 100(6):1395-405. PubMed ID: 17115413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAPK inhibition by 1alpha,25(OH)2-Vitamin D3 in breast cancer cells. Evidence on the participation of the VDR and Src.
    Rossi AM; Capiati DA; Picotto G; Benassati S; Boland RL
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):287-90. PubMed ID: 15225787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid up-regulates myeloid ICAM-3 expression and function in a cell-specific fashion--evidence for retinoid signaling pathways in the mast cell lineage.
    Babina M; Mammeri K; Henz BM
    J Leukoc Biol; 2001 Mar; 69(3):361-72. PubMed ID: 11261782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours.
    Russell DS; Rassnick KM; Erb HN; Vaughan MM; McDonough SP
    J Comp Pathol; 2010; 143(2-3):223-6. PubMed ID: 20334872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
    Bauer JA; Thompson TA; Church DR; Ariazi EA; Wilding G
    Prostate; 2003 May; 55(3):159-67. PubMed ID: 12692781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vitamin D receptor-mediated activation of phosphatidylinositol 3-kinase (PI3Kalpha) plays a role in the 1alpha,25-dihydroxyvitamin D3-stimulated increase in steroid sulphatase activity in myeloid leukaemic cell lines.
    Hughes PJ; Lee JS; Reiner NE; Brown G
    J Cell Biochem; 2008 Apr; 103(5):1551-72. PubMed ID: 17879954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that TRPC3 is a molecular component of the 1alpha,25(OH)2D3-activated capacitative calcium entry (CCE) in muscle and osteoblast cells.
    Santillán G; Baldi C; Katz S; Vazquez G; Boland R
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):291-5. PubMed ID: 15225788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of adhesion molecules on cord-blood-derived, cultured human mast cells and effect of dexamethasone on intercellular adhesion molecule-1 expression on the mast cells treated by phorbol myristate acetate.
    Inamura H; Kurosawa M; Kuwasaki T; Kamada Y; Kayaba H; Chihara J
    Allergy; 2001 Jul; 56(7):672-8. PubMed ID: 11421927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.